Corium Revenue and Competitors

Location

N/A

Total Funding

Industry

Estimated Revenue & Valuation

  • Corium's estimated annual revenue is currently $35M per year.(i)
  • Corium's estimated revenue per employee is $73,529

Employee Data

  • Corium has 476 Employees.(i)
  • Corium grew their employee count by -5% last year.

Corium's People

NameTitleEmail/Phone
1
Chief People OfficerReveal Email/Phone

What Is Corium?

Corium International, Inc. is a leader in applying advanced transdermal delivery systems and related technologies to address unmet medical needs. We have developed two highly differentiated state of the art transdermal technologies: MicroCor®, a biodegradable microstructure patch technology for active delivery of proteins, peptides and vaccines large molecules that require active transport through the skin Corplex™, a novel adhesive system and patch technology for delivery of small molecules that may otherwise be difficult to formulate and deliver With a team that includes the innovators of many of the market-leading transdermal products, Corium combines great technologies with a strong track record of successfully designing, developing and producing therapeutic products.

keywords:N/A

N/A

Total Funding

476

Number of Employees

$35M

Revenue (est)

-5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Corium News

2022-04-19 - Vaccines Delivery Devices Market Size 2022-2030| Key ...

Vaccines Delivery Devices Market Size 2022-2030| Key Players – 3M, BD, Corium International, Gerresheimer ... New Jersey, USA,- The research study...

2022-03-30 - 29 Mar 2022 Corium's Adlarity faces a fiercely competitive ...

Corium's Adlarity (donepezil hydrochloride) has recently received FDA approval as a treatment for patients with mild, moderate,...

2022-03-22 - Corium To Present at Academy of Managed Care Pharmacy ...

BOSTON, March 28, 2022 /PRNewswire/ -- Corium, Inc., a commercial-stage biopharmaceutical company leading the development and commercialization...

2007-09-27 - Life sciences briefing: Thursday, Sept. 27, 2007

Featured companies: AstraZeneca, Atlantis Components, Cara Therapeutics, CardioMems, Corium International, New Ortho Polymers, Osprey Pharmaceuticals, Othera Pharmaceuticals, StrataGent Life Sciences Corium acquires Stratagent, raises $25.1M for “transdermal” drugs — Corium International, a Men ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A48922%N/A
#2
$155.9M491N/AN/A
#3
$184.2M5084%N/A
#4
$155.3M5526%$320M
#5
$15M5577%N/A